
CapsoVision, Inc. (CV)
CV Stock Price Chart
Explore CapsoVision, Inc. interactive price chart. Choose custom timeframes to analyze CV price movements and trends.
CV Company Profile
Discover essential business fundamentals and corporate details for CapsoVision, Inc. (CV) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Specialties
IPO Date
2 Jul 2025
Employees
99.00
Website
https://capsovision.comCEO
Kang-Huai Wang
Description
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
CV Financial Timeline
Browse a chronological timeline of CapsoVision, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Aug 2026
EPS estimate is -$0.13, while revenue estimate is $3.81m.
Earnings released on 14 May 2026
EPS came in at -$0.15 falling short of the estimated -$0.13 by -15.38%, while revenue for the quarter reached $2.79m , missing expectations by -6.18%.
Earnings released on 26 Mar 2026
EPS came in at -$0.16 surpassing the estimated -$0.17 by +5.88%, while revenue for the quarter reached $3.90m , missing expectations by -6.05%.
Earnings released on 13 Nov 2025
EPS came in at -$0.17 falling short of the estimated -$0.14 by -21.43%, while revenue for the quarter reached $3.54m , missing expectations by -17.74%.
Earnings released on 14 Aug 2025
EPS came in at -$2.02 falling short of the estimated -$0.11 by -1.74k%, while revenue for the quarter reached $3.32m , beating expectations by +2.11%.
CV Stock Performance
Access detailed CV performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.